<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/can-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/can-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2017-09-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2017-09-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/can-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions/"},"url":"https://clinicaltree.github.io/posts/can-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions/"}</script><title>Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions? | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1506790800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Sep 30, 2017 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Elena Pena MD</a> </em>, <em> <a href="">MacArinze Ojiaku MD</a> </em>, <em> <a href="">Joao R. Inacio MD</a> </em>, <em> <a href="">Ashish Gupta MD</a> </em>, <em> <a href="">D. Blair Macdonald MD FRCPC</a> </em>, <em> <a href="">Wael Shabana MD PhD</a> </em>, <em> <a href="">Jean M. Seely MD FRCPC</a> </em>, <em> <a href="">Frank J. Rybicki MD PhD</a> </em>, <em> <a href="">Carole Dennie MD FRCPC</a> </em>, <em> <a href="">Rebecca E. Thornhill PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="3022 words"> <em>16 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The study aimed to identify a radiomic approach based on CT and or magnetic resonance (MR) features (shape and texture) that may help differentiate benign versus malignant pleural lesions, and to assess if the radiomic model may improve confidence and accuracy of radiologists with different subspecialty backgrounds.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Twenty-nine patients with pleural lesions studied on both contrast-enhanced CT and MR imaging were reviewed retrospectively. Three texture and three shape features were extracted. Combinations of features were used to generate logistic regression models using histopathology as outcome. Two thoracic and two abdominal radiologists evaluated their degree of confidence in malignancy. Diagnostic accuracy of radiologists was determined using contingency tables. Cohen’s kappa coefficient was used to assess inter-reader agreement. Using optimal threshold criteria, sensitivity, specificity, and accuracy of each feature and combination of features were obtained and compared to the accuracy and confidence of radiologists.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The CT model that best discriminated malignant from benign lesions revealed an AUC CT = 0.92 ± 0.05 ( <em>P</em> &lt; 0.0001). The most discriminative MR model showed an AUC MR = 0.87 ± 0.09 ( <em>P</em> &lt; 0.0001). The CT model was compared to the diagnostic confidence of all radiologists and the model outperformed both abdominal radiologists ( <em>P</em> &lt; 0.002), whereas the top discriminative MR model outperformed one of the abdominal radiologists ( <em>P</em> = 0.02). The most discriminative MR model was more accurate than one abdominal ( <em>P</em> = 0.04) and one thoracic radiologist ( <em>P</em> = 0.02).</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Quantitative textural and shape analysis may help distinguish malignant from benign lesions. A radiomics-based approach may increase diagnostic confidence of abdominal radiologists on CT and MR and may potentially improve radiologists’ accuracy in the assessment of pleural lesions characterized by MR.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Pleural disease has a wide variety of etiologies, ranging from benign inflammatory and infectious processes to aggressive malignancy . The most common pleural malignancy is metastatic adenocarcinoma. The second most common is malignant pleural mesothelioma (MPM) , a tumor strongly associated with asbestos exposure. MPM portends a poor prognosis, has a median survival rate of 9–17 months, and may be fatal in a few months if untreated .</p><p>Although a definitive diagnosis of malignant pleural disease often relies on tissue histopathology, it is challenging to differentiate MPM from benign reactive mesothelial cells . Several invasive procedures may be required to obtain sufficient tissue , and a large panel of immunohistochemical markers is often required to establish the correct diagnosis. Thus, imaging and in particular computed tomography (CT) plays a major role for both diagnosis and follow-up of pleural lesions . Radiologists currently use conventional visual assessment of morphologic findings to distinguish benign from malignant pleural disease. However, benign pleural reaction may resemble malignancy, as the pleura can react to disparate pathologic processes in a similar way, namely thickening and effusions .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population"><span class="mr-2">Study Population</span><a href="#study-population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-acquisition"><span class="mr-2">Imaging Acquisition</span><a href="#imaging-acquisition" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="slice-selection-segmentation-and-imaging-analysis"><span class="mr-2">Slice Selection, Segmentation, and Imaging Analysis</span><a href="#slice-selection-segmentation-and-imaging-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/0_1s20S1076633217301332.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/0_1s20S1076633217301332.jpg" alt="Figure 1, Examples of segmentations of nodular (a, b) and smooth (c, d) pleural lesions on CT and MR. Axial contrast-enhanced CT (a) and MR images (b) showing the segmentation ( yellow lines ) of a nodular pleural lesion involving the left anterior mediastinal pleura. Core biopsies of the lesion were diagnostic of mesothelioma. Axial contrast-enhanced CT (b) and MR (d) images show the segmentation ( yellow lines ) of the smooth pleural thickening along the right posterior costal pleura. Core biopsies revealed fibrous pleural thickening without malignant features. Additionally, the lesion was stable on follow-up imaging for 3 years, indicating benignity. CT, computed tomography; MR, magnetic resonance. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/1_1s20S1076633217301332.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/1_1s20S1076633217301332.jpg" alt="Figure 2, Representative contrast-enhanced CT (a) and MR images (d) demonstrating an enhancing lobulated pleural lesion of an 88-year-old male. Pleuroscopy revealed mesothelioma with both epithelioid and sarcomatoid elements. The selected areas depicted in (a) and (d) demonstrate the lesion chosen for segmentation ( b and e , respectively). The rectangular areas in (a) and (d) are magnified 400% (b) and 600% (e) , respectively, to better depict the segmentation. (c, f) Show screen captures of the software program utilized to extract the shape and textural features (MaZda) of the segmented lesion. CT, computed tomography; MR, magnetic resonance." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="subjective-analysis"><span class="mr-2">Subjective Analysis</span><a href="#subjective-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="quantitative-texture-and-shape-analysis"><span class="mr-2">Quantitative Texture and Shape Analysis</span><a href="#quantitative-texture-and-shape-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Mean=1Np∑ijg(i,j) M</p><p>e</p><p>a</p><p>n</p><p>=</p><p>1</p><p>N</p><p>p</p><p>∑</p><p>i</p><p>j</p><p>g</p><p>(</p><p>i</p><p>,</p><p>j</p><p>)</p><p>where <em>g</em> ( <em>i, j</em> ) indicates the gray-level intensity of pixel ( <em>i, j</em> ), and <em>N p</em> the number of pixels.</p><p>f8=−∑2Ngi=1px+y(i)log{px+y(i)},wherepx+y(k)=∑Ngi=1i+j=k∑Ngj=1P(i,j),k=2,3,…2Ng f</p><p>8</p><p>=</p><p>−</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>2</p><p>N</p><p>g</p><p>p</p><p>x</p><p>+</p><p>y</p><p>(</p><p>i</p><p>)</p><p>log</p><p>{</p><p>p</p><p>x</p><p>+</p><p>y</p><p>(</p><p>i</p><p>)</p><p>}</p><p>,</p><p>where</p><p>p</p><p>x</p><p>+</p><p>y</p><p>(</p><p>k</p><p>)</p><p>=</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>i</p><p>+</p><p>j</p><p>=</p><p>k</p><p>N</p><p>g</p><p>∑</p><p>j</p><p>=</p><p>1</p><p>N</p><p>g</p><p>P</p><p>(</p><p>i</p><p>,</p><p>j</p><p>)</p><p>,</p><p>k</p><p>=</p><p>2</p><p>,</p><p>3</p><p>,</p><p>…</p><p>2</p><p>N</p><p>g</p><p>f9=∑Ngi=1∑Ngj=1P(i,j)log(P(i,j)) f</p><p>9</p><p>=</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>N</p><p>g</p><p>∑</p><p>j</p><p>=</p><p>1</p><p>N</p><p>g</p><p>P</p><p>(</p><p>i</p><p>,</p><p>j</p><p>)</p><p>log</p><p>(</p><p>P</p><p>(</p><p>i</p><p>,</p><p>j</p><p>)</p><p>)</p><p>where <em>N g</em> represents the number of distinct gray levels, <em>g i</em> , and indicates the <em>ith</em> gray-level value ( <em>i</em> = 1, 2, …, <em>N</em> ); <em>P(i, j)</em> indicates the joint probability of two pixels having particular co-occurring values <em>i, j</em> = 1, 2, …, <em>N g</em> ; and µ x , µ y , σ x , and σ y indicate means and standard deviations of the row and column sums of the co-occurrence matrix , .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Rc=2A/π√∑D/π R</p><p>c</p><p>=</p><p>2</p><p>A</p><p>/</p><p>π</p><p>∑</p><p>D</p><p>/</p><p>π</p><p>where <em>A</em> indicates the area of the lesion (number of pixels) and <em>D</em> denotes the contour profile diameter.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient Demographics, Diagnosis, and Pleural Lesion Characteristics</p><p>Patients Benign Lesions Malignant Lesions_n_ 12 17 Gender (M/F) 8/4 16/1 Age (mean ± SD) 67 ± 16 73 ± 10 Lesion diagnosis ( <em>N</em> ) Benign (12) Malignant (17) Etiology ( <em>n</em> , diagnosis) 5 chronic inflammation</p><p>2 pleural plaques</p><p>1 solitary fibrous tumor</p><p>4 benign (stable over 2 years on imaging studies) 12 mesothelioma</p><p>8 epithelioid</p><p>3 biphasic</p><p>1 sarcomatoid 5 metastasis</p><p>4 adenocarcinoma (2 in the lungs, 1 in the breast, 1 in the salivary gland)</p><p>1 pleomorphic undifferentiated sarcoma Involvement of mediastinal pleura, <em>n</em> (%) 0 (0%) 9 (53%)<em>P</em> = 0.003 Pleural thickening &gt;1 cm 6 (50%) 15 (88%)<em>P</em> = 0.04 Nodular contour, <em>n</em> (%) 3 (25%) 15 (88%)<em>P</em> = 0.001 Circumferential pleural thickening, <em>n</em> (%) 0 (0%) 15 (88%)<em>P</em> &lt; 0.0001</p><p>F, female; M, male; SD, standard deviation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/2_1s20S1076633217301332.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/2_1s20S1076633217301332.jpg" alt="Figure 3, Comparison of receiver operating characteristic curves for thoracic radiologists 1 and 2 and abdominal radiologists 1 and 2 for identification of malignant lesions on CT and MR. The thoracic radiologists' AUC CT (SE) was 0.91 (0.07) and 0.92 (0.03) ( P &lt; .0001), and the AUC MR (SE) was 0.96 (0.03) and 0.79 (0.07), both significantly different from AUC = 0.5 ( P &lt; .0001). The abdominal radiologists' AUC CT was 0.51 (0.09) and 0.56 (0.11), and the AUC MR was 0.53 (0.10) and 0.61 (0.10), and they were not significantly different from AUC = 0.5 ( P &gt; 0.05). AUC, area under the curve; CT, computed tomography; MR, magnetic resonance; SE, standard error." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/3_1s20S1076633217301332.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/3_1s20S1076633217301332.jpg" alt="Figure 4, Box and whisker plots depicting medians, interquartile ranges, and extrema for each of the texture features (a) mean, (b) f 8 , and (c) f 9 , and shape features (d) S1, (e) N i , and (f) R c for both benign and malignant pleural lesions. On CT, the median values of f 8 (sum entropy) and S1 (a feature related to maximum thickness of the contour skeleton) were significantly lower in benign compared to malignant lesions ( P &lt; 0.002 and P = 0.03, respectively). Additionally, on MR, the median values of N i (a feature related to the number of skeleton branches) demonstrated significant differences comparing benign to malignant lesions ( P = 0.02). CT, computed tomography; MR, magnetic resonance." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/4_1s20S1076633217301332.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CanCTandMRShapeandTexturalFeaturesDifferentiateBenignVersusMalignantPleuralLesions/4_1s20S1076633217301332.jpg" alt="Figure 5, Individual receiving operating characteristic curves of textural features (a) mean, (b) f 8 , and (c) f 9 , and shape features (d) S1, (e) N i , and (f) R c on CT and MR for identification of malignant lesions. The features most capable of delineating malignant from benign lesions on CT images were f 8 (AUC CT = 0.75 ± 0.10) and S1 (AUC CT = 0.74 ± 0.11), both ( P &lt; 0.05). On MR, the descriptors mean, N i , and S1 reached significance, with AUC MR = 0.70 ± 0.10, AUC MR = 0.76 ± 0.10, and AUC MR = 0.71 ± 0.11 ( P &lt; 0.05), respectively. AUC, area under the curve; CT, computed tomography; MR, magnetic resonance." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Receiver Operating Characteristics for Combinations of CT or MR Features</p><p>Model CT MRI AUC (SE) \* <em>P</em> Criterion Se (%) Sp (%) AUC (SE) \* <em>P</em> Criterion Se (%) Sp (%) Shape: S1 + R c + N i 0.78 (0.09) 0.001 &gt;0.63 71 83 0.75 (0.10) 0.01 &gt;0.39 88 67 Shape: S1 + R c 0.69 (0.10) 0.07 &gt;0.69 47 92 0.68 (0.11) 0.10 &gt;0.50 82 67 Texture: f 8 +  f 9 + mean 0.86 (0.07) &lt;0.0001 &gt;0.48 82 83 0.72 (0.10) 0.02 &gt;0.74 41 100 Texture: f 8 + mean 0.84 (0.08) &lt;0.0001 &gt;0.58 82 83 0.70 (0.10) 0.06 &gt;0.33 100 33 Shape and texture: S1 + R c + f 8 + mean 0.92 (0.05) &lt;0.0001 &gt;0.35 94 75 0.76 (0.09) 0.005 &gt;0.67 53 92 Shape and texture: S1 + f 8 + mean 0.85 (0.07) &lt;0.0001 &gt;0.52 82 83 0.70 (0.10) 0.048 &gt;0.32 100 33 Shape and texture: R c + f 8 + mean 0.86 (0.08) &lt;0.0001 &gt;0.45 88 75 0.77 (0.09) 0.004 &gt;0.50 71 75 Shape and texture: S1 + R c + f 8 0.87 (0.07) &lt;0.0001 &gt;0.42 100 75 0.68 (0.11) 0.09 &gt;0.56 71 75 Shape and texture: S1 + R c + mean 0.75 (0.10) 0.01 &gt;0.53 71 75 0.76 (0.09) 0.005 &gt;0.39 94 50 Shape and texture: S1 + f 8 0.76 (0.10) 0.01 &gt;0.53 82 67 0.64 (0.11) 0.23 &gt;0.57 71 67 Shape and texture: S1 + mean 0.73 (0.11) 0.03 &gt;0.56 76 75 0.72 (0.10) 0.03 &gt;0.56 65 75 Shape and texture: R c + f 8 0.86 (0.08) &lt;0.0001 &gt;0.57 82 83 0.65 (0.11) 0.18 &gt;0.51 76 67 Shape and texture: R c + mean 0.77 (0.10) 0.01 &gt;0.70 59 92 0.76 (0.09) 0.005 &gt;0.39 94 50 PC-1 0.67 (0.11) 0.11 ≤-1.81 71 75 0.69 (0.10) 0.06 &gt;16.93 41 100 PC-2 0.63 (0.12) 0.28 &gt;-8.27 94 42 0.76 (0.11) 0.01 &gt;-2.28 76 75 PC-3 0.52 (0.11) 0.90 ≤-2.20 47 67 0.75 (0.10) 0.01 ≤0.41 71 83 PC-1 + PC-2 0.71 (0.11) 0.07 &gt;0.54 82 75 0.77 (0.10) 0.01 &gt;0.43 100 58 PC-1 + PC-2 + PC-3 0.71 (0.11) 0.06 &gt;0.55 76 75 0.87 (0.09) 0.0001 &gt;0.45 100 83</p><p>AUC, area under the curve; CT, computed tomography; MR, magnetic resonance; MRI, magnetic resonance imaging; Se, sensitivity; Sp, specificity.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Difference in AUC (95% CI) Between CT Shape and Textural Features and Subjective Visual Assessment (Confidence)</p><p>Reader CT Models MRI Models S1 + R c + f 8 + Mean R c + f 8 + Mean PC-1 + PC-2 + PC-3 S1 + R c + f 8 + Mean R c + f 8 + Mean PC-1 + PC-2 + PC-3 Thoracic radiologist 1 0.01 [−0.15 to 0.17]; 0.90 0.05 [−0.15 to 0.25]; 0.64 −0.20 [−0.06 to 0.47]; 0.14 −0.21 [0.04 to 0.37]; 0.01 −0.20 [0.03 to 0.36]; 0.02 −0.09 [−0.09 to 0.28]; 0.33 Thoracic radiologist 2 0.00 [−0.16 to 0.17]; 0.95 0.05 [−0.15 to 0.25]; 0.60 −0.21 [−0.06 to 0.47]; 0.13 −0.04 [−0.20 to 0.27]; 0.76 −0.03 [−0.20 to 0.26]; 0.82 0.08 [−0.14 to 0.30]; 0.50 Abdominal radiologist 1 0.41 [0.17 to 0.66]; 0.001 0.35 [0.06 to 0.64]; 0.02 0.20 [−0.09 to 0.50]; 0.18 0.23 [−0.05 to 0.50]; 0.10 0.24 [−0.03 to 0.50]; 0.08 0.34 [0.05 to 0.62]; 0.02 Abdominal radiologist 2 0.36 [0.13 to 0.60]; 0.002 0.30 [0.05 to 0.56]; 0.02 0.15 [−0.18 to 0.48]; 0.37 0.14 [−0.15 to 0.43]; 0.34 0.15 [−0.12 to 0.42]; 0.27 0.26 [−0.04 to 0.56]; 0.10</p><p>AUC, area under the curve; CI, confidence interval; CT, computed tomography; MRI, magnetic resonance imaging; PC, principal components.</p><p>Values indicate difference in AUC between shape and texture model and radiologist readers [95% CI]; <em>P</em> value.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Difference in Accuracy Between Shape and Textural Models and Subjective Diagnosis (Benign vs Malignant)</p><p>Reader CT Models MRI Models S1 + R c + f 8 + Mean R c + f 8 + Mean PC-1 + PC-2 + PC-3 S1 + R c + f 8 + Mean R c + f 8 + Mean PC-1 + PC-2 + PC-3 Thoracic radiologist 1 3.5% [−12.2 to 15.4]; 1.00 −6.9% [−11.5 to 18.9]; 0.69 −17.2% [−6.2 to 29.3]; 0.18 −17.2% [−6.2 to 29.3]; 0.18 −20.7% [1.7 to 20.7]; 0.03 −6.9% [−8.4 to 13.6]; 0.63 Thoracic radiologist 2 13.8% [−8.3 to 25.8]; 0.29 −10.3% [−12.5 to 26.4]; 0.51 0.0% [−26.0 to 26.0]; 1.00 −3.5% [−26.0 to 31.7]; 1.00 −0.0% [−23.9 to 23.9]; 1.00 27.6% [3.8 to 34.3]; 0.02 Abdominal radiologist 1 13.8% [−8.3 to 25.8]; 0.29 10.3% [−10.1 to 22.4]; 0.45 0.0% [−18.9 to 18.9]; 1.00 3.5% [−22.3 to 27.6]; 1.00 6.9% [−16.4 to 26.1]; 0.75 20.7% [−1.5 to 27.4]; 0.07 Abdominal radiologist 2 13.8% [−10.5 to 29.9]; 0.34 10.3% [−10.1 to 22.4]; 0.45 0.0% [−15.8 to 15.8]; 1.00 0.0% [−18.9 to 18.9]; 1.00 3.5% [−17.9 to 22.5]; 1.00 24.1% [1.1 to 30.9]; 0.04</p><p>CI, confidence interval; CT, computed tomography; PC, principal components.</p><p>Values indicate difference in % accuracy between shape and texture model and binary diagnosis by radiologist readers [95% CI]; <em>P</em> value.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion-1"><span class="mr-2">Conclusion</span><a href="#conclusion-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Leff A., Hopewell P.C., Costello J.: Pleural effusion from malignancy. Ann Intern Med 1978; 88: pp. 532-537.</p><li><p>2. Bonomo L., Feragalli B., Sacco R., et. al.: Malignant pleural disease. Eur J Radiol 2000; 34: pp. 98-118.</p><li><p>3. Tsao A.S., Wistuba I., Roth J.A., Kindler H.L.: Malignant pleural mesothelioma. J Clin Oncol 2009; 27: pp. 2081-2090.</p><li><p>4. Roggli V.L., Kolbeck J., Sanfilippo F., Shelburne J.D.: Pathology of human mesothelioma. Etiologic and diagnostic considerations. Pathol Annu 1987; 22: pp. 91-131.</p><li><p>5. Wang Z.J., Reddy G.P., Gotway M.B., et. al.: Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004; 24: pp. 105-119.</p><li><p>6. Aisner J.: Current approach to malignant mesothelioma of the pleura. Chest 1995; 107: pp. 332S-344S.</p><li><p>7. Nickell L.T., Lichtenberger J.P., Khorashadi L., et. al.: Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics 2014; 34: pp. 1692-1706.</p><li><p>8. Leung A.N., Muller N.L., Miller R.R.: CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154: pp. 487-492.</p><li><p>9. Knuuttila A., Kivisaari A., Kivisaari M., et. al.: Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma. Acta Radiol 2001; 42: pp. 502-507.</p><li><p>10. Hierholzer J., Luo L., Bittner R.C., et. al.: MRI and CT in the differential diagnosis of pleural disease. Chest 2000; 118: pp. 604-609.</p><li><p>11. Benamore R.E., O’Doherty M.J., Entwisle J.J.: Use of imaging in the management of malignant pleural mesothelioma. Clin Radiol 2005; 60: pp. 1237-1247.</p><li><p>12. Gillies R.J., Kinahan P.E., Hricak H.: Radiomics: images are more than pictures, they are data. Radiology 2016; 278: pp. 563-577.</p><li><p>13. Kido S., Kuriyama K., Higashiyama M., et. al.: Fractal analysis of small peripheral pulmonary nodules in thin-section CT: evaluation of the lung-nodule interfaces. J Comput Assist Tomogr 2002; 26: pp. 573-578.</p><li><p>14. Dennie C., Thornhill R., Sethi-Virmani V., et. al.: Role of quantitative computed tomography texture analysis in the differentiation of primary lung cancer and granulomatous nodules. Quant Imaging Med Surg 2016; 6: pp. 6-15.</p><li><p>15. Gibbs P., Turnbull L.W.: Textural analysis of contrast-enhanced MR images of the breast. Magn Reson Med 2003; 50: pp. 92-98.</p><li><p>16. Ahmed A., Gibbs P., Pickles M., Turnbull L.: Texture analysis in assessment and prediction of chemotherapy response in breast cancer. J Magn Reson Imaging 2013; 38: pp. 89-101.</p><li><p>17. Simon I., Snow P.B., Marks L.S., et. al.: Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot study. Anal Quant Cytol Histol 2000; 22: pp. 445-452.</p><li><p>18. Wibmer A., Hricak H., Gondo T., et. al.: Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol 2015; 25: pp. 2840-2850.</p><li><p>19. Ganeshan B., Miles K.A., Young R.C.D., et. al.: Texture analysis in non-contrast enhanced CT: impact of malignancy on texture in apparently disease-free areas of the liver. Eur J Radiol 2009; 70: pp. 101-110.</p><li><p>20. Thornhill R.E., Golfam M., Sheikh A., et. al.: Differentiation of lipoma from liposarcoma on MRI using texture and shape analysis. Acad Radiol 2014; 21: pp. 1185-1194.</p><li><p>21. Bayanati H., Thornhill E., Souza C.A., et. al.: Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer?. Eur Radiol 2015; 25: pp. 480-487.</p><li><p>22. Andersen M.B., Harders S.W., Ganeshan B., et. al.: CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. Acta Radiol 2016; 57: pp. 669-676.</p><li><p>23. Hodgdon T., McInnes M.D., Schieda N., et. al.: Can quantitative CT texture analysis be used to differentiate fat-poor renal angiomyolipoma from renal cell carcinoma on unenhanced CT images?. Radiology 2015; 276: pp. 787-796.</p><li><p>24. Schieda N., Thornhill R.E., Al-Subhi M., et. al.: Diagnosis of sarcomatoid renal cell carcinoma with CT: evaluation by qualitative imaging features and texture analysis. AJR Am J Roentgenol 2015; 204: pp. 1013-1023.</p><li><p>25. Collewet G., Strzelecki M., Mariette F.: Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging 2004; 22: pp. 81-91.</p><li><p>26. Haralick R.M., Shanmugam K., Dinstein I.: Textural features for image classification. IEEE Trans Syst Man Cybern 1973; 3: pp. 610-621.</p><li><p>27. DeLong E.R., DeLong D.M., Clarke-Pearson D.L.: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: pp. 837-845.</p><li><p>28. Davnall F., Yip C.S., Ljunggvist G., et. al.: Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?. Insights Imaging 2012; 3: pp. 573-589.</p><li><p>29. O’Connor J.P., Rose C.J., Waterton J.C., et. al.: Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res 2015; 21: pp. 249-257.</p><li><p>30. Sureka B., Thukral B.B., Mittal M.K., et. al.: Radiological review of pleural tumors. Indian J Radiol Imaging 2013; 23: pp. 313-320.</p><li><p>31. Ganeshan B., Panayiotou E., Burnand K., et. al.: Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 2012; 22: pp. 796-802.</p><li><p>32. Li H., Zhu Y., Burnside E.S., et. al.: MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology 2016; 281: pp. 382-391.</p><li><p>33. Wang H., Guo X.H., Jia Z.W., et. al.: Multilevel binomial logistic prediction model for malignant pulmonary nodules based on texture features of CT image. Eur J Radiol 2010; 74: pp. 124-129.</p><li><p>34. Way T.W., Sahiner B., Chan H.P., et. al.: Computer-aided diagnosis of pulmonary nodules on CT scans: improvement of classification performance with nodule surface features. Med Phys 2009; 36: pp. 3086-3098.</p><li><p>35. Kassner A., Thornhill R.E.: Texture analysis: a review of neurologic MR imaging applications. AJNR Am J Neuroradiol 2010; 31: pp. 809-816.</p><li><p>36. Jordanov M., Bregman J., Montgomery K., Heidel M.: Curbside radiology consults: how does the time allotted for review, level of training, and subspecialization affect interpretation accuracy?. Clin Imaging 2015; 39: pp. 497-503.</p><li><p>37. Yip S.S., Aerts H.J.: Applications and limitations of radiomics. Phys Med Biol 2016; 61: pp. R150-R166.</p><li><p>38. Ravanelli M., Farina D., Morassi M., et. al.: Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy. Eur Radiol 2013; 23: pp. 3450-3455.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-24/'>Volume 24</a>, <a href='/categories/issue-10/'>Issue 10</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Can%20CT%20and%20MR%20Shape%20and%20Textural%20Features%20Differentiate%20Benign%20Versus%20Malignant%20Pleural%20Lesions?%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcan-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Can%20CT%20and%20MR%20Shape%20and%20Textural%20Features%20Differentiate%20Benign%20Versus%20Malignant%20Pleural%20Lesions?%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcan-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcan-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions%2F&text=Can%20CT%20and%20MR%20Shape%20and%20Textural%20Features%20Differentiate%20Benign%20Versus%20Malignant%20Pleural%20Lesions?%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-diagnostic-accuracy-meta-analysis-of-ct-and-mri-for-the-evaluation-of-small-bowel-crohn-disease/"><div class="card-body"> <em class="small" data-ts="1506790800" data-df="ll" > Sep 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Diagnostic Accuracy Meta-analysis of CT and MRI for the Evaluation of Small Bowel Crohn Disease</h3><div class="text-muted small"><p> Rationale and Objectives This study aimed to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) and computed tomography (CT) in assessing small bowel (SB) Crohn disease (CD). Ma...</p></div></div></a></div><div class="card"> <a href="/posts/andragogic-approaches-to-continuing-medical-education/"><div class="card-body"> <em class="small" data-ts="1506790800" data-df="ll" > Sep 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Andragogic Approaches to Continuing Medical Education</h3><div class="text-muted small"><p> Consider two very different approaches to radiology continuing medical education (CME) meetings. At meeting number one, radiologists receive a program book, determine which lectures they are intere...</p></div></div></a></div><div class="card"> <a href="/posts/applying-quantitative-ct-image-feature-analysis-to-predict-response-of-ovarian-cancer-patients-to-ch/"><div class="card-body"> <em class="small" data-ts="1506790800" data-df="ll" > Sep 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy</h3><div class="text-muted small"><p> Rationale and Objectives The study aimed to investigate the role of applying quantitative image features computed from computed tomography (CT) images for early prediction of tumor response to che...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/breast-density-legislation-in-new-england/" class="btn btn-outline-primary" prompt="Older"><p>Breast Density Legislation in New England</p></a> <a href="/posts/correlation-between-screening-mammography-interpretive-performance-on-a-test-set-and-performance-in/" class="btn btn-outline-primary" prompt="Newer"><p>Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
